MedTrace Logo

Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia

NCT00801814 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2008-12-04

No results posted yet for this study

Summary

To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide \[NVP\] reduces postprandial glycemia when added to a liquid and a solid meal.

Conditions

  • Blood Glucose, Postprandial

Interventions

DIETARY_SUPPLEMENT

PolyGlycopleX (PGX)

2.5 grams of PGX

DIETARY_SUPPLEMENT

PolyGlycopleX (PG)

5.0 grams of PGX

DIETARY_SUPPLEMENT

PolyGlycopleX

7.5 grams of PGX

DIETARY_SUPPLEMENT

Control

0g of PGX

DIETARY_SUPPLEMENT

Second Control

0g of PGX

Sponsors & Collaborators

  • InovoBiologic Inc.

    collaborator INDUSTRY

  • Canadian Center for Functional Medicine

    collaborator OTHER

  • Glycemic Index Laboratories, Inc

    lead INDUSTRY

Principal Investigators

  • Alexandra L Jenkins, PhD, RD · Glycemic Index Laboratories, Inc

  • Thomas MS Wolever, MD · Glycemic Index Laboratories, Inc

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2006-05-31
Completion
2006-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00801814 on ClinicalTrials.gov